Abbott and Celera form molecular diagnostics alliance
This article was originally published in Clinica
Executive Summary
Abbott Laboratories and Celera Diagnostics are forming an alliance aimed at strengthening their positions in the fast-growing $1bn molecular diagnostic market. The collaboration will focus on the development, manufacture and marketing of a broad range of in vitro molecular diagnostic products, for disease detection, disease progression monitoring and choice of selection.